Company Profile
Shanghai eliv pharmaceutical Co.,Ltd. was founded in 2011. Eliv focus on R&D and production of APIs and intermediates. The major members in the team have Ph.D. or MSEE degrees from prominent universities in China and overseas. Except for first-class production and advanced research facilities, Eliv also has rich experience at intermediates and APIs, analytical method development and impurity research, new drug certificate to declare. Eliv has a comprehensive management system and the production base in Nantong passed the c-GMP certification.
Eliv cooperate with domestic famous design institutes to promote the enterprises growing rapidly, boost the existing and developing ability at the market competition. Now, Eliv’s products have been used in cardiovascular and cerebrovascular, anti-cancer, anti-Virus, respiratory system and so on. Major customers include but not limited in Mexico,Spain, Taiwan and so on.
Products
- 1,2,3,4-Tetrahydrobenzo-H-quinolin-3-ol CAS: 5423-67-6
- 3,4-Dihydro-6-hydroxy-2(1H)-quinolinone CAS: 54197-66-9
- 4,4'-di-(-2-Hydroxyethylthio)diphenyl sulfone CAS: 53680-66-3
- 4-(1-Methylethyl)-1,3-benzenediol CAS: 23504-03-2
- 4-Aminopyrrolo[2,3-d]pyrimidinehydrogen sulfate CAS: 769951-32-8
- 4-Ethyl-1,3-benzenediol CAS: 2896-60-8
- 4-Methylresorcinol CAS: 496-73-1
- Acamprosate calcium CAS: 77337-73-6
- Acetic acid calcium salt CAS: 62-54-4
- Adenosine cyclophosphate CAS: 60-92-4
- Adenylosuccinic acid CAS: 19046-78-7
- Benzetimide hydrochloride CAS: 5633-14-7
- Bucladesine sodium CAS: 16980-89-5
- Buphenine hydrochloride CAS: 849-55-8
- Butroxydim CAS: 138164-12-2
- Clanobutin CAS: 30544-61-7
- Clanobutin sodium CAS: 74755-21-8
- Cyclopentolate hydrochloride CAS: 5870-29-1
- Diphenylpyraline hydrochloride CAS: 132-18-3
- Efinaconazole CAS: 164650-44-6
